European Approval for Nirogacestat Marks Major Milestone for SpringWorks Therapeutics
SpringWorks Therapeutics has achieved a significant regulatory milestone with the European Commission granting marketing authorization for its therapy, Nirogacestat (Ogsiveo). ...